Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antimonial |
| gptkbp:administeredBy |
gptkb:amphotericin_B
|
| gptkbp:ATCCode |
gptkb:P01CB01
|
| gptkbp:CASNumber |
12202-17-4
|
| gptkbp:chemicalFormula |
C12H21NaO16Sb
|
| gptkbp:contraindication |
pregnancy
cardiac disease renal impairment |
| gptkbp:discoveredBy |
1937
|
| gptkbp:drugBank |
gptkb:DB12866
|
| gptkbp:eliminationHalfLife |
2.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
sodium stibogluconate
|
| gptkbp:KEGGID |
gptkb:D08513
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits parasite metabolism
|
| gptkbp:origin |
synthetic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:pubChem |
23663860
|
| gptkbp:PubChem_CID |
CHEMBL1201192
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
gptkb:arrhythmia
fatigue pancreatitis elevated liver enzymes arthralgia myalgia |
| gptkbp:UNII |
0D1C08J32G
|
| gptkbp:usedFor |
leishmaniasis
|
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:Leishmania_donovani
|
| gptkbp:bfsLayer |
5
|